¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦8Â÷ International Congress on Lipid & Atherosclerosis (ICoLA 2019) : 2019-09-06

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦8Â÷ International Congress on Lipid & Atherosclerosis (ICoLA 2019) : 2019-09-06
±³À°ÀÏÀÚ : 2019-09-06
±³À°Àå¼Ò : Conrad Seoul Hotel Grand ballroom ¿Ü 2°³·ë  
±³À°ÁÖÁ¦ : Á¦8Â÷ International Congress on Lipid & Atherosclerosis (ICoLA 2019)
ÁÖÃÖ±â°ü : Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ
´ã´çÀÚ : ICoLA»ç¹«±¹
¿¬¶ôó : 02-2135-3618  
À̸ÞÀÏ : secretariat@icola.org      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 22 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í Àü¹®ÀÇ, ±³¼ö »çÀüµî·Ï 10¸¸¿ø / ÇöÀåµî·Ï 12¸¸¿øÀüÀÓÀÇ, Çлý, ±âŸ µî »çÀüµî·Ï 4¸¸¿ø / ÇöÀåµî·Ï 5¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-06 Grand Ballroom 1+2+3 09:00~09:30 Killer Clones: Clonal Hematopoiesis as a New Causal Risk Factor for Cardiovascular Disease  Kenneth Walsh(University of Virginia USA) 
È޽Ġ09-06 Grand Ballroom 1 09:30~09:40 Break  () 
±³À°½Ã°£ 09-06 Grand Ballroom 1 09:40~10:00 Blood Pressure Variability  Sripal Bangalore(New York University USA) 
±³À°½Ã°£ 09-06 Grand Ballroom 1 10:00~10:20 Body Weight Fluctuation  Tae Jung Oh(Seoul National University Korea) 
±³À°½Ã°£ 09-06 Grand Ballroom 1 10:20~10:40 Glycemic Variability and Cardiovascular Outcome  Jae Hyeon Kim(Sungkyunkwan University Korea) 
±³À°½Ã°£ 09-06 Grand Ballroom 1 10:40~11:00 Cholesterol Variability and Health Outcomes  Seung-Hwan Lee(The Catholic University of Korea Korea) 
Åä·Ð 09-06 Grand Ballroom 1 11:00~11:10 Discussion  () 
È޽Ġ09-06  11:10~11:20 Coffee Break  () 
±³À°½Ã°£ 09-06 Grand Grand Ballroom 1+2+31 11:30~12:10 The Benefits of GLP 1-RA and SGLT2 Inhibitor for the CV Outcomes: What Is Similar or Different?  Stefano Del Prato(University of Pisa Italy) 
±³À°½Ã°£ 09-06 Grand Ballroom 1 12:10~12:40 Optimizing Cholesterol Lowering Therapy in High-risk Patients  Robert S. Rosenson(The Mount Sinai Hospital in New York USA) 
±³À°½Ã°£ 09-06 Grand Ballroom 1 12:40~13:10 Ideal DM Patients care management and CVD prevention : Focusing on Guidelines  Hye Soon Kim(Keimyung University Korea) 
È޽Ġ09-06  13:10~13:20 Break  () 
±³À°½Ã°£ 09-06 Grand Ballroom 1+2+3 13:20~13:50 Metabolic Reprogramming of Macrophage in Atherosclerosis: Is it All about Cholesterol?  Laurent Yvan-Charvet(Institut national de la sante et de la recherche medicale France) 
È޽Ġ09-06  13:50~14:00 Break  () 
±³À°½Ã°£ 09-06 Grand Ballroom 1 14:00~14:20 Why Should We Consider Ezetimibe in Lipid Guidelines?  Soo-Joong Kim(Kyung Hee University Korea) 
±³À°½Ã°£ 09-06 Grand Ballroom 1 14:20~14:40 Role of PCSK9 Inhibitors in Lipid Guidelines and Future  Yu Kataoka(National Cerebral & Cardiovascular Centre Japan) 
±³À°½Ã°£ 09-06 Grand Ballroom 1 14:40~15:00 Impact of The Coronary Artery Calcium Score on Patient Selection for Statin Therapy  Joshua Mitchell(Washington University USA) 
±³À°½Ã°£ 09-06 Grand Ballroom 1 15:00~15:20 LDL Target in Lipid Guidelines?  Su Jin Jeong(Sejong Hospital Korea) 
Åä·Ð 09-06 Grand Ballroom 1 15:20~15:30 Discussion  () 
±³À°½Ã°£ 09-06 Grand Ballroom 1 16:30~16:50 Diabetes and the Heart  Chi Young Shim(Yonsei Univeristy Korea) 
±³À°½Ã°£ 09-06 Grand Ballroom 1 16:50~17:10 Cardiovascular Effects of GLP-1 Agonists  Vincent Woo(University of Manitoba Canada) 
±³À°½Ã°£ 09-06 Grand Ballroom 1 17:10~17:30 Cardiovascular Effects of SGLT2 inhibitors  Subodh Verma(University of Toronto Canada) 
±³À°½Ã°£ 09-06 Grand Ballroom 1 17:30~17:50 Hypoglycemia and Cardiovascular Disease in Type 2 Diabetes  Seung-Hyun Ko(The Catholic University of Korea Korea) 
Åä·Ð 09-06 Grand Ballroom 1 17:50~18:00 Discussion  () 
±³À°½Ã°£ 09-06 Grand Ballroom 2 09:00~10:05 How Coronary Artery Calcium Testing Can Guide Management Decisions for Primary Cardiovascular Prevention  Sang-HaKhurram Nasirk Lee(Yale University USA) 
±³À°½Ã°£ 09-06 Grand Ballroom 2 10:05~10:30 What Can Lipid Genetics Do for Patients with Dyslipidemia?  Sang-Hak Lee(Yonsei University Korea) 
±³À°½Ã°£ 09-06 Grand Ballroom 2 10:30~10:55 Digital Health Can Improve Dyslipidemia Care  Jung-Won Suh(Seoul National University Korea) 
Åä·Ð 09-06 Grand Ballroom 2 10:55~11:10 Discussion  () 
±³À°½Ã°£ 09-06 Grand Ballroom 3 09:40~10:05 Interaction of Genetic and Lifestyles in Dyslipidemia Risk in Koges  Sunmin Park(Hoseo University Korea) 
±³À°½Ã°£ 09-06 Grand Ballroom 3 10:05~10:30 Epidemiology of Dietary and Lifestyle Factors and Cardiovascular Disease: Experiences Japanese Population-based Studies  Kazumasa Yamagishi(University of Tsukuba Japan) 
±³À°½Ã°£ 09-06 Grand Ballroom 3 10:30~10:55 Dietary Factors and Prevention of Dyslipidemia  Yunkyoung Lee(Jeju National University Korea) 
Åä·Ð 09-06 Grand Ballroom 3 10:55~11:10 Discussion  () 
±³À°½Ã°£ 09-06 Grand Ballroom 2 14:00~14:20 Pulsatile Hemodynamics in Heart Failure  Thomas Weber(Klinikum Wels-Grieskirchen Austria) 
±³À°½Ã°£ 09-06 Grand Ballroom 2 14:20~14:40 Arterial Stiffness and Circardian Pattern of Blood Pressure  Jin-Sun Park(Ajou University Medical Center Korea) 
±³À°½Ã°£ 09-06 Grand Ballroom 2 14:40~15:00 The Clinical Usefulness of Brachial-ankle Pulse Wave Velocity  Masanori Munakata(Tohoku Rosai Hospital Japan) 
±³À°½Ã°£ 09-06 Grand Ballroom 2 15:00~15:20 Arterial Stiffness and Coronary Artery Disease  Hack-Lyoung Kim(Seoul National University Korea) 
Åä·Ð 09-06 Grand Ballroom 2 15:20~15:30 Discussion  () 
±³À°½Ã°£ 09-06 Park Ballroom3 14:00~14:20 PCSK9 Inhibitors : Impact on High-risk Patients and Appropriate Clinical Use  Atsushi Nohara(Kanazawa University Japan) 
±³À°½Ã°£ 09-06 Park Ballroom3 14:20~14:40 Fibrates  Shun Ishibashi(Jichi Medical University Japan) 
±³À°½Ã°£ 09-06 Park Ballroom3 14:40~15:00 Usefulness of Ezetimibe in the Management of Dyslipidemia and NAFLD  Hyekyung Yang(Sungkyunkwan University Korea) 
±³À°½Ã°£ 09-06 Park Ballroom3 15:00~15:20 Role of Omega-3 Fatty Acid in Cardiometabolic Risk Reduction  Soo Lim(Seoul National University Korea) 
Åä·Ð 09-06 Park Ballroom3 15:20~15:30 Discussion  () 
±³À°½Ã°£ 09-06 Grand Ballroom 2 16:30~16:50 Target Blood Pressures in Recent Hypertension Guidelines, Updated Reasons and Clinical Implications  Jinho Shin(Hanyang University Korea) 
±³À°½Ã°£ 09-06 Grand Ballroom 2 16:50~17:10 Effect of Pharmacological Therapies on Regression of Coronary Plaque in Patients with Ischemic Heart Disease  Hideki Ishii(Nagoya University Japan) 
±³À°½Ã°£ 09-06 Grand Ballroom 2 17:10~17:30 Management of Blood Pressure and Hyperlipidemia in Patients with Atherosclerosis  Hye jin Yoo(Korea University Guro Hospital Korea) 
±³À°½Ã°£ 09-06 Grand Ballroom 2 17:30~17:50 Anti-hypertensive Effects of FMD (Fasting Mimicking Diet) and Cardiovascular Disease  Manlio Vinciguerra(St'Anne University Czech Republic) 
±³À°½Ã°£ 09-06 Grand Ballroom 2 17:50~18:00 Discussion  () 
±³À°½Ã°£ 09-06 Grand Ballroom 3 16:30~16:50 The Role of LYVE1+ Macrophage in Atherosclerosis  Veronique Angeli(National University of Singapore Singapore) 
±³À°½Ã°£ 09-06 Grand Ballroom 3 16:50~17:10 Cytokine Mediated Control Of Microbiota and Inflammation in Atherosclerosis  Ekaterina Koltsova(Fox Chase Cancer Center USA) 
±³À°½Ã°£ 09-06 Grand Ballroom 3 17:10~17:30 A Lipocalin-2 (NGAL)-Iron Axis Integrates Innate Immunity, Microbiome and Cardiometabolic Disease.  Gary Sweeney(York University Canada) 
±³À°½Ã°£ 09-06 Grand Ballroom 3 17:30~17:50 Perivascular Adipose Tissues and Atherosclerosis  Aimin Xu(The University of Hong Kong Hong Kong) 
Åä·Ð 09-06 Grand Ballroom 3 17:50~18:00 Discussion  () 
±³À°½Ã°£ 09-06 Park Ballroom3 09:40~10:05 Basic of Single Cell RNA Sequencing and Application to Cancer Studies  Hae-Ock Lee(Samsung Medical Center Korea) 
±³À°½Ã°£ 09-06 Park Ballroom3 10:05~10:30 Dissecting Cellular Heterogeneity Using Single-cell RNA-seq  Jong Kyoung Kim(DGIST Korea) 
±³À°½Ã°£ 09-06 Park Ballroom3 10:30~10:55 TNF Promotes SREBP Activity and Binding to Inflammatory Genes to Activate Macrophages and Limit Tissue Repair  Sung-ho Park(UNIST Korea) 
Åä·Ð 09-06 Park Ballroom3 10:55~11:10 Discussion  () 
±³À°½Ã°£ 09-06 Grand Ballroom 3 14:00~14:25 Cholesterol Everywhere : Analytical and Clinical Aspcets  Man-Ho Choi(KIST Korea) 
±³À°½Ã°£ 09-06 Grand Ballroom 3 14:25~14:50 Metabolomics: How Can We Use It for Metabolic Disease- Lessons from a Monogenic Mitochondrial Disorder  Christine Des Rosiers(Universite de Montreal Canada) 
±³À°½Ã°£ 09-06 Grand Ballroom 3 14:50~15:15 Clonal Hematopoiesis: Is It a New Risk Factor for Metabolic Dysfunction?  Changhee Jung(University of Virginia USA) 
Åä·Ð 09-06 Grand Ballroom 3 15:15~15:30 Discussion  () 
±³À°½Ã°£ 09-06 Park Ballroom3 16:30~16:50 Epidemiology and Genetic Studies Showing an Association of Lp(a) with Elevated Cardiovascular Risk and Aortic Valve Disease  Brian Tomlinson(The Chinese University of Hong Kong Hong Kon) 
±³À°½Ã°£ 09-06 Park Ballroom3 16:50~17:10 Role of Lp(a) as an ASCVD Risk Factor and Its Heritability in Familial Hypercholesterolemia: Implications for Cascade Testing Programs  Gerald F Watts(The University of Western Australia Australia) 
±³À°½Ã°£ 09-06 Park Ballroom3 17:10~17:30 Strategies for Lowering Lp(a) Levels  Sang-Hyun Kim(Seoul National University Korea) 
±³À°½Ã°£ 09-06 Park Ballroom3 17:30~17:50 The Implication of Lipoprotein(a) in Metabolic Diseases  Eun-Jung Rhee(Sungkyunkwan University Korea) 
Åä·Ð 09-06 Park Ballroom3 17:50~18:00 Discussion  () 
±³À°½Ã°£ 09-06 Park Studio 14:00~14:15 Analysis of 18F-fluorodeoxyglucose and 18F-fluoride Positron Emission Tomography on Stroke Patients with Carotid Atherosclerosis  Jeong-Min Kim(Jeong-Min Kim) 
±³À°½Ã°£ 09-06 Park Studio 14:15~14:30 Effect of Niacin on Carotid Atherosclerosis in Patients at Low-density Lipoprotein-cholesterol Goal but with High Lipoprotein (a) Levels: 2-Year Follow Up Study  Chan Joo Lee(Yonsei University Korea) 
±³À°½Ã°£ 09-06 Park Studio 14:30~14:45 Intensity of Statin Treatment in Patients with Acute Myocardial Infarction and Very Low LDL Cholesterol  Kyung Hoon Cho(Chonnam National University Korea) 
±³À°½Ã°£ 09-06 Park Studio 14:45~15:00 Effects of Obesity and Family History of Diabetes on the Association of CETP rs6499861 with HDL Cholesterol Level in Koreans  Sun Ha Jee(Yonsei University Korea) 
±³À°½Ã°£ 09-06 Park Studio 15:00~15:15 Curcumin Suppresses Acrolein-Induced COX-2 Expression and Prostaglandin Production in Endothelial Cells  Yong Seek Park(Kyung Hee University Korea) 
±³À°½Ã°£ 09-06 Park Studio 15:15~15:30 Anti-malarial Drugs Reduce Vascular Smooth Muscle Cell Proliferation Via Activation of AMPK and Inhibition of Smad3 Signaling  Chang-Hoon Woo(Yeungnam University Korea) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦8Â÷ International Congress on Lipid & Atherosclerosis (ICoLA 2019) : 2019-09-06""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °­³²¼¼ºê¶õ½ºº´¿ø Á¦6ȸ ôÃßÄ¡·á±â±â¸íÇ°È­¿¬±¸È¸ Á¤±â Çмú´ëȸ : 2019-09-06
´ÙÀ½±Û ¼¼ºê¶õ½ºº´¿ø ¾ÈÀ̺ñÀÎÈÄ°úº´¿ø ¾È°ú ±Ý¿äÁý´ãȸ : 2019-09-06
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 45 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 35 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 36 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 44 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 38 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 29 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 12 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 12 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 26 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 14 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 12 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 31 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 23 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 26 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 22 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷